Antipsychotic metabolic monitoring — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Weight, glucose or HbA1c, lipids and blood pressure
Olanzapine can cause weight gain, dyslipidaemia and impaired glucose regulation. Baseline and ongoing cardiometabolic monitoring is important for reducing long-term harm. The other options either delay appropriate care, use an unsuitable medicine, or miss the main safety issue.
Reference: BNF; NICE CKS